A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.
November 19, 2023
Premier Weighs in with FDA on AI in Drug Manufacturing
Premier recommends ways for FDA to incorporate emerging technologies into drug development and provide clarity for manufacturers.
November 19, 2023
Premier Submits Comments on DEA’s Proposed Quotas for Controlled Substances
Premier urges the DEA to ensure reductions in opioid manufacturing quotas do not exacerbate recent drug shortages.
November 14, 2023
Premier, Inc. Joins the End Drug Shortages Alliance
Builds on efforts to create healthier pharmaceutical markets that ensure continuous access and prevent shortages that can compromise patient care.
November 02, 2023
Statement on CMS' Final Remedy for the 340B-Acquired Drug Payment Policy
Premier responds to CMS' final rule to compensate hospitals for past underpayments for 340B drugs.
October 18, 2023
Three Ways Pharmacy is Driving Healthcare Innovation
Happy National Pharmacy Week 2023. And thank you to all pharmacists for your tireless work and dedication to improving the health of communities you serve.
September 15, 2023
Video: Exela's Domestic Pharmaceutical Manufacturing Facility in Action
See how Premier, Exela® Pharma Sciences and Premier members are protecting the future of the pharmaceutical supply chain together.
September 15, 2023
Bridge the Gap: Conduct a <797> Gap Analysis to Extend BUDs
Pharmacy Purchasing & Products Magazine |
Premier's Kevin Hansen and Cone Health's Austin S. Price highlight how compounders can achieve longer beyond-use dates (BUDs) for compounded sterile preparations through enhanced quality...
August 31, 2023
Premier Comments on CMS Proposed Remedies for Reversing 340B Payment Cuts
Premier urged CMS to adopt policies to ensure that hospitals and other 340B entities are appropriately compensated for past 340B payment shortfalls.
August 30, 2023
Premier Comments on FDA Compounding Draft Guidance
Premier responded to the FDA’s draft guidance on the statutory prohibition on wholesaling for certain compounded drugs.
August 24, 2023
A Look Inside Exela's Domestic Pharmaceutical Manufacturing Facility
The Premier team, member hospitals, and government and community leaders visit Exela's facility in Lenoir, NC.
August 08, 2023
Premier Weighs in with FDA on Using Artificial Intelligence and Machine Learning in Drug Development
Premier outlines ways that FDA can best incorporate emerging technologies into drug development and provide clarity for clinical trial innovators.
July 27, 2023
Premier Responds to Congressional 340B RFI
Premier urges Congress to take action to improve the 340B program to allow safety net providers continued access to discounted drug prices.
